Showing results (751-760 of 1,032) with videos related to

Sort By:
Pageof 104
Oncogene|June 10, 2025
HPV status impacts oncobacteria abundance and prognostic relevance in head and neck squamous cell carcinomaTravis D Kerr, Natalie L Silver, Radhika Duggal, et al.
Annals of Surgical Oncology|August 12, 2022
Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In SituMegan E Tesch, Shoshana M Rosenberg, Laura C Collins, et al.
BMC Public Health|January 11, 2025
Young, Empowered & strong (YES): a study protocol paper for a randomized controlled trial of an mHealth symptom monitoring and self-management intervention for adolescent and young adult (AYA) breast cancer survivorsKate E Dibble, Shoshana M Rosenberg, Craig Snow, et al.
Transplantation and Cellular Therapy|October 2, 2023
Family Caregiver Experiences in the Inpatient and Outpatient Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Settings: A Qualitative StudyTamryn F Gray, Khuyen M Do, Hermioni L Amonoo, et al.
Journal of Psychosocial Oncology|December 28, 2024
Feasibility of implementing a culturally and linguistically adapted telephone-based cognitive-behavioral therapy (CBT) intervention for depression and anxiety with Hispanic and Latino cancer survivorsSuzanne C Danhauer, Janet A Tooze, Tebianne Abubaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studiesJ Nemunaitis, C Poole, J Primrose, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammationT S Blackwell, F E Yull, C L Chen, et al.
Gut|February 14, 1998
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study GroupJ J Misiewicz, A W Harris, K D Bardhan, et al.
Alimentary Pharmacology & Therapeutics|September 3, 1998
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study GroupA W Harris, J J Misiewicz, K D Bardhan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2022
Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast CancerJennifer R Bellon, Nabihah Tayob, David D Yang, et al.
Pageof 104